Pharmafile Logo
Pharmafocus logo
Advanced Search
set your sights image

Novartis launches Facebook ‘retina app’

October 15, 2013
Medical Communications AMD, Bayer, Lucentis, Novartis, set your sights

Novartis, the world’s biggest eye-care drugmaker, has launched a new Facebook retina app to raise awareness of retinal disease. The …

News
astrazeneca image

AstraZeneca pays $460m for cancer specialists

October 15, 2013
Research and Development, Sales and Marketing ADC, AstraZeneca, Cancer, MedImmune, spirogen

AstraZeneca’s biologics arm MedImmune has bought cancer biotech firm Spirogen and set up a licensing deal with ADC Therapeutics for …

News

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

News
Pixuvri image

Price cut not enough for Pixuvri

October 15, 2013
Sales and Marketing Cell Therapeutics, NICE, pixuvri

NICE is still saying no to Cell Therapeutics’ lymphoma drug Pixuvri, despite the firm offering a discount on the treatment’s …

News
Roche image

Roche poised to get even bigger in biomanufacturing

October 15, 2013
Manufacturing and Production Jobs, Merck, Roche, cuts

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …

News
ian_tomlinson_bia_web

String of appointments to BIA Board

October 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, appointments

The BioIndustry Association has appointed Kevin Cox, Donna Hackett, Jane Osbourn, Stephen Taylor, Patrick Verheyen and Tim Watts to its …

Appointment
Ranbaxy image

FDA throws Ranbaxy a manufacturing lifeline

October 15, 2013
Manufacturing and Production FDA, Ranbaxy, recall

Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …

News

Boehringer submits NSCLC pill

October 14, 2013
Sales and Marketing

Boehringer Ingelheim has submitted its oral triple angiokinase inhibitor nintedanib for scrutiny by the European Medicines Agency. Nintedanib was impressive …

News
Eric Low image

Trials and tribulations

October 14, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, eric low, myeloma, transparency

I have been chief executive of Myeloma UK since its inception 17 years ago, and its unique bedside to bench …

Feature
ben_atkins_inventiv

inVentiv Health creates two senior appointments



October 14, 2013
Medical Communications, Research and Development, Sales and Marketing inVentiv Health

The comms division of inVentiv Health has appointed two 
social media veterans to expand its digital footprint. Emma D’Arcy joins …

Appointment
zytiga image

Janssen agrees Zytiga deal

October 14, 2013
Sales and Marketing AstraZeneca, Janssen, Zytiga

Janssen has agreed to co-promote its once-daily prostate cancer pill Zytiga with AstraZeneca in Japan for an undisclosed sum. A …

News

Vetter swells filling capacity with $100m investment

October 11, 2013
Manufacturing and Production API, Vetter, sterile liquid

German contract development and manufacturing organisation (CDMO) Vetter says it is planning to invest over $100 million across its production …

News
pfizer image

Mixed tale for Pfizer psoriasis drug

October 11, 2013
Sales and Marketing Enbrel, Pfizer, psoriasis, tofacitinib

Pfizer has seen its novel, oral Janus kinase (JAK) inhibitor tofacitinib turn in a mixed showing in late-stage trials in …

News
US shutdown image

US shutdown affecting medical science

October 11, 2013
Research and Development, Sales and Marketing FDA, Obama, Obamacare, us shutdown

American scientists and the latest Nobel Prize winners have condemned the US shutdown this week saying it is putting scientific …

News
Teva image

Teva to axe 5,000 jobs in savings drive

October 11, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Copaxone, FDA, Teva, cuts

The world’s largest generic drugmaker Teva will cut around 5,000 jobs from its global workforce as it looks to speed-up …

News
Alzheimer’s image

Alzheimer’s research ‘turning point’

October 11, 2013
Research and Development, Sales and Marketing Alzheimer's, Alzheimer’s, MRC, research

There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …

News
bryan_picture

Glide Pharma confirms Board changes and chairman

October 11, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Glide Pharma, morton

Pharma development and device firm Glide Pharma has appointed EUSA Pharma’s founder Bryan Morton as a non-executive chairman. The company …

Appointment

PAN hires new associate director and head of Art

October 10, 2013
Medical Communications, Research and Development, Sales and Marketing Pan, burchell, ohare, reiss

Creative agency PAN has strengthened its senior team with the arrival of Jan Reiss as associate director and the promotion …

Appointment
NHS image

NHS ‘behind the curve’, warns government

October 10, 2013
Medical Communications, Sales and Marketing NHS, curve, technology

The government is on track to deliver a paperless NHS by 2018, according to parliamentary undersecretary of state for health …

News
vincent_warnery_sanofi

Sanofi appoints senior vice president

October 10, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, warnery

Vincent Warnery has been appointed as the senior vice president to Sanofi’s new Global Consumer Healthcare Division. He will remain …

Appointment
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026